Workflow
KORU Medical Systems(KRMD)
icon
Search documents
KORU Medical Systems(KRMD) - 2020 Q1 - Earnings Call Presentation
2020-05-05 21:55
Q1 2020 Financial Results May 5, 2020 Nasdaq: KRMD DISCLAIMER / NON-GAAP MEASURES This presentation contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "expect", "plan," "goal," "seek," "vision, "confident," "future," "will" and similar references to future periods. Examples of forward-looking statements include, among others, statements we make rega ...
KORU Medical Systems(KRMD) - 2019 Q4 - Annual Report
2020-03-04 21:57
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 0-12305 REPRO MED SYSTEMS, INC. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) (IRS Employer Identification No.) ...
KORU Medical Systems(KRMD) - 2019 Q4 - Earnings Call Transcript
2020-02-26 19:26
KORU Medical Systems (NASDAQ:KRMD) Q4 2019 Earnings Conference Call February 26, 2020 9:00 AM ET Company Participants Devin Sullivan - SVP, Equity Group Don Pettigrew - President and CEO Karen Fisher - CFO Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Andrew DeSilva - B. Riley FBR Operator Greetings and welcome to the KORU Medical Systems Fourth Quarter and Full Year 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and- ...
KORU Medical Systems(KRMD) - 2019 Q4 - Earnings Call Presentation
2020-02-26 14:55
NOT CALS TEMS | TM Q4 and FY 2019 CONFERENCE CALL February 26, 2020 Nasdaq: KRMD DISCLAIMER / NON-GAAP MEASURES This presentation contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "plan," "goal," "seek," "vision, "confident," "future," "will" and similar references to future periods. Examples of forward-looking statements include, among others, sta ...
KORU Medical Systems(KRMD) - 2019 Q3 - Earnings Call Transcript
2019-11-11 01:43
KORU Medical Systems (NASDAQ:KRMD) Q3 2019 Earnings Conference Call November 6, 2019 9:00 AM ET CompanyParticipants Devin Sullivan - SVP, Equity Group Don Pettigrew - President & CEO Karen Fisher - CFO Conference Call Participants Alex Nowak - Craig-Hallum Operator Greetings and welcome to the KORU Medical Systems Reports Third Quarter 2019 Financial Results Conference Call. [Operator Instructions] It is now my pleasure to introduce your host, Devin Sullivan, Senior Vice President of The Equity Group. Thank ...
KORU Medical Systems(KRMD) - 2019 Q3 - Earnings Call Presentation
2019-11-07 17:18
Q3 2019 CONFERENCE CALL November 6, 2019 Nasdaq: KRMD DISCLAIMER / NON-GAAP MEASURES This presentation contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "plan," "goal," "seek," "vision, "confident," "future," "will" and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding o ...
KORU Medical Systems(KRMD) - 2019 Q3 - Quarterly Report
2019-11-06 21:22
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________. Commission File Number: 0-12305 REPRO MED SYSTEMS, INC. (Exact name of registrant as specified in its charter) New York 13-30448 ...
Repro Med Systems (REPR) Presents At 4th Annual Dougherty & Company Institutional Investor Conference - Slideshow
2019-09-11 17:02
HIgHoFlo Super26" Subcutaneous Safety Needle Sets INVESTOR PRESENTATION Dougherty & Co. Institutional Investor Conference September 2019 OTCQX: REPR INVESTOR PRESENTATION JUNE 26, 2019 Home and Specialty Infusion Products that Improve the Patient Experience DISCLAIMER & NON-GAAP MEASURES OTCQX: REPR This presentation contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified ...
KORU Medical Systems(KRMD) - 2019 Q2 - Earnings Call Transcript
2019-08-10 18:04
Repro Med Systems, Inc. (REPR) Q2 2019 Earnings Conference Call August 8, 2019 9:00 AM ET Company Participants Devin Sullivan - SVP, Equity Group Don Pettigrew - President & CEO Karen Fisher - CFO Manuel Marques - COO Conference Call Participants Alex Nowak - Craig-Hallum Operator Greetings and welcome to the RMS Medical Second Quarter 2019 Financial Results conference call. [Operator Instructions]. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host Devin Sulliva ...
KORU Medical Systems(KRMD) - 2019 Q2 - Quarterly Report
2019-08-07 21:04
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2019 Or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________. Commission File Number: 0-12305 REPRO MED SYSTEMS, INC. (Exact name of registrant as specified in its charter) N/A (Former Name, Form ...